Paradigm Biopharmaceuticals Ltd.ASX: PAR

PAR Selects Advanced Clinical as CRO for Phase 3

Jan 31, 2025 at 2:40 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment